Beneficial effects of nafazatrom on ischemic reperfused myocardium-Reference-Cited by-同舟云学术

Beneficial effects of nafazatrom on ischemic reperfused myocardium

Published:1984-06 Issue:1 Volume:102 Page:63-70
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Shea Michael J.,Murtagh James J.,Jolly Stanley R.,Abrams Gerald D.,Pitt Bertram,Lucchesi Benedict R.

Publisher

Elsevier BV

Subject

Pharmacology

Reference31 articles.

1. A mechanism for the production of ethylene from methional;Beauchamp;J. Biol. Chem.,1970

2. Inhibition of arterial thrombosis and platelet function by nafazatrom;Buchanan;Thromb. Res.,1982

3. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion;Bush;J. Cardiovasc. Pharm.,1982

4. Nafazatrom, prostacyclin and ZK366374 suppress reperfusion-induced ventricular fibrillation in anesthetized greyhounds;Coker;Br. J. Pharmacol.,1983

5. The effects of oral nafazatrom (BAYg6575) on canine coronary artery thrombosis and myocardial ischemia;Fiedler;Basic Res. Cardiol.,1983

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutrophils and myocardial reperfusion injury;Pharmacology & Therapeutics;1996-01

2. Neutrophil mediated myocardial injury;International Journal of Biochemistry;1993-02

3. Effect of anti-CD18 antibody on myocardial neutrophil accumulation and infarct size after ischemia and reperfusion in dogs.;Circulation;1993-02

4. Phenothiazine and phenoxazine derivatives of nafazatrom. In vitro evaluation as 5-lipoxygenase and iron-dependent lipid peroxidation inhibitors.;Bioorganic & Medicinal Chemistry Letters;1992-01

5. Early Thrombolysis by Recombinant Tissue-Plasminogen Activator Is Beneficial to the Ischemic Myocardium.;Journal of Pharmacobio-Dynamics;1992